乳腺癌中的瘤突变负担:当前的证据,挑战和机遇
Romualdo Barroso-Sousa1,2, Jana Priscila Pacífico1,2, Sarah Sammons3,4,5
1Dasa Institute for Education and Research (IEPD), Brasilia 71635-580, DF, Brazil.
Cancers
|August 12, 2023
概括
瘤突变负担 (TMB) 是许多癌症免疫治疗反应的生物标志物. 它在转移性乳腺癌中的作用需要进一步调查,以指导治疗决策.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 瘤突变负担 (TMB) 与各种固体瘤中的新抗原负载,T细胞透和对免疫检查点抑制剂 (ICI) 的反应有关.
- 根据KEYNOTE-158研究,抗PD-1抗体布利祖马布已被批准用于基于TMB≥10个突变/兆基的高级固体瘤.
- 在KEYNOTE-158研究中排除了转移性乳腺癌患者,使其作为ICI治疗预测生物标志物的作用在这个人群中不清楚.
研究的目的:
- 审查当前对转移性乳腺癌中TMB的理解.
- 讨论建立TMB作为转移性乳腺癌免疫治疗的预测生物标志物的挑战和机会.
主要方法:
- 在转移性乳腺癌中研究TMB和免疫治疗的研究文献综述.
- 分析现有的临床试验数据和研究结果.
主要成果:
- TMB与乳腺癌治疗反应的相关性尚未完全确立.
- 需要进一步的研究来验证TMB在这个特定的患者群体中作为预测生物标志物.
结论:
- 确立TMB作为转移性乳腺癌免疫治疗的可靠预测生物标志物存在重大挑战.
- 识别和克服这些挑战对于优化乳腺癌患者免疫治疗策略至关重要.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.5K
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
12.7K
相关概念视频
Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
